Hans-Peter Rudolf

Hans-Peter Rudolf

Directeur/Bestuurslid bij
Phosphate Therapeutics Ltd.
60 jaar
Commercial Services
Consumer Services
Health Technology

Profiel

Hans-Peter Rudolf is currently a Director at Phosphate Therapeutics Ltd. He previously worked as an Audit Partner at Ernst & Young LLP from 2003 to 2006, and as a Partner at Ernst & Young AG.
He was also the Head-Group Accounting at Bellefontaine Investments AG from 2011 to 2017, and an Audit Partner at Crowe LLP from 2006 to 2010.
From 2017 to 2020, he served as the Chief Financial Officer at Vicarius Pharma AG.
Rudolf holds an undergraduate degree from Cleveland State University and the University of Zurich.
He is currently the Chief Financial Officer at Shield Therapeutics Plc.

Actieve functies van Hans-Peter Rudolf

BedrijvenFunctieBegin
Directeur/Bestuurslid 12-05-2021

Eerdere bekende functies van Hans-Peter Rudolf

BedrijvenFunctieEinde
SHIELD THERAPEUTICS PLC Financieel Directeur/CFO 20-10-2023
Financieel Directeur/CFO 01-04-2020
Comptroller/Controller/Auditor 01-04-2017
Corporate Officer/Principal 01-12-2010
Corporate Officer/Principal 01-07-2006
Ervaring van Hans-Peter Rudolf in detail bekijken

Opleiding van Hans-Peter Rudolf

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

84

Eerstegraads connecties

9

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit9

Commercial Services

Consumer Services

Consumer Services

Commercial Services

Finance

Commercial Services

Health Technology

Health Technology

Commercial Services

  1. Beurs
  2. Insiders
  3. Hans-Peter Rudolf